RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Evoke Pharma Stock

Evoke Pharma ROE 2024

Evoke Pharma ROE

3.02

Ticker

EVOK

ISIN

US30049G1040

WKN

A1W6DP

In 2024, Evoke Pharma's return on equity (ROE) was 3.02, a -249.94% increase from the -2.01 ROE in the previous year.

Evoke Pharma Aktienanalyse

What does Evoke Pharma do?

Evoke Pharma Inc. is a pharmaceutical company that was founded in 2007 and is based in San Diego, California. It focuses on developing innovative drugs for gastrointestinal disorders. Evoke Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Evoke Pharma's Return on Equity (ROE)

Evoke Pharma's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Evoke Pharma's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Evoke Pharma's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Evoke Pharma’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Evoke Pharma stock

What is the ROE (Return on Equity) of Evoke Pharma this year?

The ROE of Evoke Pharma this year is 3.02 undefined.

How has the Return on Equity (ROE) of Evoke Pharma developed compared to the previous year?

The ROE of Evoke Pharma has increased by -249.94% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Evoke Pharma?

A high ROE indicates that Evoke Pharma generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Evoke Pharma?

A low ROE can indicate that Evoke Pharma is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Evoke Pharma affect the company?

A change in ROE (Return on Equity) of Evoke Pharma can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Evoke Pharma?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Evoke Pharma?

Some factors that can influence Evoke Pharma's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Evoke Pharma pay?

Over the past 12 months, Evoke Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Evoke Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Evoke Pharma?

The current dividend yield of Evoke Pharma is .

When does Evoke Pharma pay dividends?

Evoke Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Evoke Pharma?

Evoke Pharma paid dividends every year for the past 0 years.

What is the dividend of Evoke Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Evoke Pharma located?

Evoke Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Evoke Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Evoke Pharma from 12/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/30/2024.

When did Evoke Pharma pay the last dividend?

The last dividend was paid out on 12/30/2024.

What was the dividend of Evoke Pharma in the year 2023?

In the year 2023, Evoke Pharma distributed 0 USD as dividends.

In which currency does Evoke Pharma pay out the dividend?

The dividends of Evoke Pharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Evoke Pharma stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Evoke Pharma

Our stock analysis for Evoke Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Evoke Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.